Cardiology Stents: Introduction
• Cardiology stents are tubes placed in the coronary artery to clear artery blockages or coronary artery stenosis. They are utilized in a procedure called percutaneous coronary intervention (PCI) or coronary angioplasty.
• This procedure is a minimally invasive procedure to treat stenosis or narrowing of the coronary arteries. Technology plays an indispensable role in the global cardiology stents market. Manufacturers undertake rigorous research and development initiatives to develop nascent products that are functionally superior to their previous versions.
Request Brochure of Report - https://www.transparencymarketresearch.com/sample/sample.php?flag=B...
Key Drivers and Restraints of Global Cardiology Stents Market
Rise in number of dialysis centers across the world
• Changes in lifestyle and controlling rapidly rising obesity rate are major factors considered for the treatment of cardio vascular disease (CVD). Percutaneous coronary intervention has become a standard treatment option preferred across the globe for CVD.
• CVDs are listed as a major cause of mortality across the world, responsible for one in every three deaths in the U.S. According to the American Heart Association, coronary heart disease is a prominent cause of death, accounting for 45% of all the deaths in the U.S. occurring due to heart diseases each year.
• Occurrence of restenosis after angioplasty procedure boosts the adoption of novel stents, such as drug-eluting and bioresorbable, which are known to drastically reduce the frequency of restenosis
• Increase in awareness about the technological innovations in interventional cardiology and cost effectiveness of the procedure propel stents production
Request COVID Analysis on Cardiology Stents Market – https://www.transparencymarketresearch.com/sample/sample.php?flag=c...
Stringent Regulations for Product Approvals
• Approval of medical devices is considered to be expensive. Coronary stents fall under the category III devices of the U.S. FDA. These devices require submission and approval of pre-market approval (PMA) application prior to commercial marketing in the U.S.
• The requirements of clinical and pre-clinical data for stents engage the sponsor and manufacturer for a long period of time. Resources of manufacturers and investors such as time and money are spent on conducting safety testing and clinical pharmacology and toxicology testing of drug substance in case of DES. The FDA’s regulatory procedures are comparatively time-consuming as compared to that of EMA. Hence, commercialization of stents takes more time in the U.S. as compared to that in Europe.
• In 2011, Abbott Vascular received marketing approval for its first bioresorbable stent in Europe, while the same device received the FDA approval in the U.S. in 2016
• Hence, prolonged procedures of drug approval by regulatory authorities in the U.S. deter manufacturers from opting for development and commercialization of stents
Enquiry Before Buying – https://www.transparencymarketresearch.com/sample/sample.php?flag=E...
Cardiology Stents Market: Segmentation
• In terms of product, the global cardiology stents market can be divided into bare metal stents, drug-eluting stents, bioresorbable stents, and others
• In terms of application, the global cardiology stents market can be split into coronary artery, carotid artery, iliac artery, and others
• Based on end-user, the global cardiology stents market can be segregated into hospitals, specialty clinics, and others
Asia Pacific Cardiology Stents Market to Expand at a Rapid Pace
• In terms of region, the global cardiology stents market can be segmented into North America, Europe, Asia Pacific, Latin America, and Middle East & Africa
• North America dominates the global cardiology stents market, followed by Europe and Asia Pacific nations such as Japan and China. High geriatric population, lifestyle changes leading to obesity and related health complications, and the advent of advanced technologies such as bio-absorbable and next generation stents are major factors driving the global cardiology stents market.
• However, high cost of coronary stents, lack of reimbursement policies in some regions, and complications such as in-stent restenosis or thrombosis are major factors restraining the global market. However, novel technologies in clinical trials to address the unmet needs and emerging economies such as China, India, Brazil and others are likely to offer significant opportunities to manufacturers operating in the market.
Leading Players Operating in Global Cardiology Stents Market
The global cardiology stents market was highly fragmented in 2019. Key players operating in the global cardiology stents market are:
• Abbott
• Boston Scientific Corporation
• BIOTRONIK AG
• Cardinal Health
• Cook Medical
• Lifetech Scientific
• Medtronic
• Terumo Corporation
About Us
Transparency Market Research is a next-generation market intelligence provider, offering fact-based solutions to business leaders, consultants, and strategy professionals.
Our reports are single-point solutions for businesses to grow, evolve, and mature. Our real-time data collection methods along with ability to track more than one million high growth niche products are aligned with your aims. The detailed and proprietary statistical models used by our analysts offer insights for making right decision in the shortest span of time. For organizations that require specific but comprehensive information we offer customized solutions through adhoc reports. These requests are delivered with the perfect combination of right sense of fact-oriented problem solving methodologies and leveraging existing data repositories.
TMR believes that unison of solutions for clients-specific problems with right methodology of research is the key to help enterprises reach right decision.”
Contact Us
Rohit Bhisey
Transparency Market Research,
90 State Street, Suite 700,
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-552-3453
Email: [email protected]
Website: https://www.transparencymarketresearch.com/